Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanoma. 1978

S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen

Twenty-two patients with cutaneous metastases of malignant melanoma were treated with intralesional injections of the methanol extraction residue of bacillus Calmette-Guerin (MER). The local reaction consisted of erythema and pustule formation followed by ulceration and tumor necrosis. Side effects included fever, chills, headache and malaise in the majority of patients; nausea, vomiting, cyanosis and hypotension occurred infrequently. Hypersensitivity reactions were not observed. Temporary abnormalities in liver function were seen in 11 of 19 patients tested. Reversible lymphopenia and thrombocytopenia developed in 7 of 17 and 7 of 18 patients, respectively. Immune function, as measured by skin tests for delayed hypersensitivity and the in vitro response of isolated lymphocytes to mitogens and microbial antigens, was not influenced by treatment with MER. Transient increases were observed in total hemolytic complement, complement components and the reduction of nitroblue-tetrazolium by neutrophils. Eight of eighteen evaluable patients showed a complete disappearance of all injected lesions. We conclude that intratumoral injection of MER is effective treatment for cutaneous metastases of malignant melanoma, with a complete response rate comparable to that observed after intralesional injection of BCG.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007271 Injections, Intradermal The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer. Intradermal Injections,Injection, Intradermal,Intradermal Injection
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D005260 Female Females
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
March 1980, Cancer,
S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
June 1978, The Nursing clinics of North America,
S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
October 1979, The Journal of antibiotics,
S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
June 1978, Cancer,
S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
August 1986, The American Journal of dermatopathology,
S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
June 1982, Cancer,
S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
January 1977, Cancer treatment reports,
S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
May 1981, Cancer,
S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
December 1977, Archives of ophthalmology (Chicago, Ill. : 1960),
S E Krown, and E Y Hilal, and C M Pinsky, and Y Hirshaut, and H J Wanebo, and J A Hansen, and A G Huvos, and H F Oettgen
December 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!